Correlation Between Morningstar Unconstrained and Flaherty
Can any of the company-specific risk be diversified away by investing in both Morningstar Unconstrained and Flaherty at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morningstar Unconstrained and Flaherty into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morningstar Unconstrained Allocation and Flaherty and Crumrine, you can compare the effects of market volatilities on Morningstar Unconstrained and Flaherty and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morningstar Unconstrained with a short position of Flaherty. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morningstar Unconstrained and Flaherty.
Diversification Opportunities for Morningstar Unconstrained and Flaherty
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Morningstar and Flaherty is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Morningstar Unconstrained Allo and Flaherty and Crumrine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flaherty and Crumrine and Morningstar Unconstrained is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morningstar Unconstrained Allocation are associated (or correlated) with Flaherty. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flaherty and Crumrine has no effect on the direction of Morningstar Unconstrained i.e., Morningstar Unconstrained and Flaherty go up and down completely randomly.
Pair Corralation between Morningstar Unconstrained and Flaherty
Assuming the 90 days horizon Morningstar Unconstrained Allocation is expected to generate 1.43 times more return on investment than Flaherty. However, Morningstar Unconstrained is 1.43 times more volatile than Flaherty and Crumrine. It trades about 0.15 of its potential returns per unit of risk. Flaherty and Crumrine is currently generating about 0.12 per unit of risk. If you would invest 1,076 in Morningstar Unconstrained Allocation on November 28, 2024 and sell it today you would earn a total of 19.00 from holding Morningstar Unconstrained Allocation or generate 1.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Morningstar Unconstrained Allo vs. Flaherty and Crumrine
Performance |
| Timeline |
| Morningstar Unconstrained |
| Flaherty and Crumrine |
Morningstar Unconstrained and Flaherty Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Morningstar Unconstrained and Flaherty
The main advantage of trading using opposite Morningstar Unconstrained and Flaherty positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morningstar Unconstrained position performs unexpectedly, Flaherty can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flaherty will offset losses from the drop in Flaherty's long position.| Morningstar Unconstrained vs. First American Funds | Morningstar Unconstrained vs. T Rowe Price | Morningstar Unconstrained vs. Davis Series | Morningstar Unconstrained vs. Prudential Emerging Markets |
| Flaherty vs. Tekla World Healthcare | Flaherty vs. Tekla Healthcare Investors | Flaherty vs. Tekla Life Sciences | Flaherty vs. Cohen And Steers |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |